Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Plaque Modification Devices Market


4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Plaque Modification Devices Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Key Insights

5.1. Technological Advancements

5.2. Disease Prevalence & Incidence Rate globally with Key countries

5.3. Reimbursement Scenario, by Region/globally

5.4. Growing Minimal Invasive Surgeries


6. Global Plaque Modification Devices Market Analysis and Forecast, by Product Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

6.3.1. Atherectomy Devices

6.3.2. Thrombectomy Devices

6.3.3. Chronic Total Occlusion (CTO) Devices

6.3.4. Embolic Protection Devices (EPD)

6.4. Market Attractiveness Analysis, by Product Type


7. Global Plaque Modification Devices Market Analysis and Forecast, by Application

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

7.3.1. Coronary Artery Disease

7.3.2. Peripheral Artery Disease

7.3.3. Neurovascular Disease

7.3.4. Others

7.4. Market Attractiveness Analysis, by Application


8. Global Plaque Modification Devices Market Analysis and Forecast, by End-user

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

8.3.1. Hospitals

8.3.2. Specialty Clinics

8.3.3. Ambulatory Surgical Centers

8.4. Market Attractiveness Analysis, by End-user


9. Global Plaque Modification Devices Market Analysis and Forecast, by Region

9.1. Key Findings

9.2. Plaque Modification Devices Market Value Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Market Attractiveness Analysis, by Region


10. North America Plaque Modification Devices Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.2. North America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

10.2.1. Atherectomy Devices

10.2.2. Thrombectomy Devices

10.2.3. Chronic Total Occlusion (CTO) Devices

10.2.4. Embolic Protection Devices (EPD)

10.3. North America Plaque Modification Devices Market Value Forecast, by Application , 2017–2027

10.3.1. Coronary Artery Disease

10.3.2. Peripheral Artery Disease

10.3.3. Neurovascular Disease

10.3.4. Others

10.4. North America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Specialty Clinics

10.4.3. Ambulatory Surgical Centers

10.5. North America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Plaque Modification Devices Market Attractiveness Analysis

10.6.1. By Product Type

10.6.2. By Application

10.6.3. By End-user

10.6.4. By Country


11. Europe Plaque Modification Devices Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Europe Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

11.2.1. Atherectomy Devices

11.2.2. Thrombectomy Devices

11.2.3. Chronic Total Occlusion (CTO) Devices

11.2.4. Embolic Protection Devices (EPD)

11.3. Europe Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

11.3.1. Coronary Artery Disease

11.3.2. Peripheral Artery Disease

11.3.3. Neurovascular Disease

11.3.4. Others

11.4. Europe Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Specialty Clinics

11.4.3. Ambulatory Surgical Centers

11.5. Europe Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Plaque Modification Devices Market Attractiveness Analysis

11.6.1. By Product Type

11.6.2. By Application

11.6.3. By End-user

11.6.4. By Country/Sub-region


12. Asia Pacific Plaque Modification Devices Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Asia Pacific Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

12.2.1. Atherectomy Devices

12.2.2. Thrombectomy Devices

12.2.3. Chronic Total Occlusion (CTO) Devices

12.2.4. Embolic Protection Devices (EPD)

12.3. Asia Pacific Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

12.3.1. Coronary Artery Disease

12.3.2. Peripheral Artery Disease

12.3.3. Neurovascular Disease

12.3.4. Others

12.4. Asia Pacific Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Specialty Clinics

12.4.3. Ambulatory Surgical Centers

12.5. Asia Pacific Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Plaque Modification Devices Market Attractiveness Analysis

12.6.1. By Product Type

12.6.2. By Application

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Plaque Modification Devices Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Latin America Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

13.2.1. Atherectomy Devices

13.2.2. Thrombectomy Devices

13.2.3. Chronic Total Occlusion (CTO) Devices

13.2.4. Embolic Protection Devices (EPD)

13.3. Latin America Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

13.3.1. Coronary Artery Disease

13.3.2. Peripheral Artery Disease

13.3.3. Neurovascular Disease

13.3.4. Others

13.4. Latin America Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Specialty Clinics

13.4.3. Ambulatory Surgical Centers

13.5. Latin America Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Plaque Modification Devices Market Attractiveness Analysis

13.6.1. By Product Type

13.6.2. By Application

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Middle East & Africa Plaque Modification Devices Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Product Type , 2017–2027

14.2.1. Atherectomy Devices

14.2.2. Thrombectomy Devices

14.2.3. Chronic Total Occlusion (CTO) Devices

14.2.4. Embolic Protection Devices (EPD)

14.3. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Application, 2017–2027

14.3.1. Coronary Artery Disease

14.3.2. Peripheral Artery Disease

14.3.3. Neurovascular Disease

14.3.4. Others

14.4. Middle East & Africa Plaque Modification Devices Market Value Forecast, by End-user, 2017–2027

14.4.1. Hospitals

14.4.2. Specialty Clinics

14.4.3. Ambulatory Surgical Centers

14.5. Middle East & Africa Plaque Modification Devices Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis

14.6.1. By Product Type

14.6.2. By Application

14.6.3. By End-user

14.6.4. By Country/Sub-region


15. Competitive Landscape

15.1. Market Share Analysis, by Company, 2018

15.2. Company Profiles

15.2.1. Boston Scientific Corporation

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Financial Overview

15.2.1.3. Product Portfolio

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. B. Braun Melsungen

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Financial Overview

15.2.2.3. Product Portfolio

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. Becton, Dickinson and Company

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Financial Overview

15.2.3.3. Product Portfolio

15.2.3.4. Strategic Overview

15.2.3.5. SWOT Analysis

15.2.4. Cardinal Health

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Financial Overview

15.2.4.3. Product Portfolio

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Medtronic

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Financial Overview

15.2.5.3. Product Portfolio

15.2.5.4. Strategic Overview

15.2.5.5. SWOT Analysis

15.2.6. Cardiovascular Systems, Inc.

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Financial Overview

15.2.6.3. Product Portfolio

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. Microvention, Inc. (Terumo)

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Financial Overview

15.2.7.3. Product Portfolio

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. Penumbra, Inc.

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Financial Overview

15.2.8.3. Product Portfolio

15.2.8.4. Strategic Overview

15.2.8.5. SWOT Analysis

15.2.9. Biotronik

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Financial Overview

15.2.9.3. Product Portfolio

15.2.9.4. Strategic Overview

15.2.9.5. SWOT Analysis

15.2.10. Stryker

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Financial Overview

15.2.10.3. Product Portfolio

15.2.10.4. Strategic Overview

15.2.10.5. SWOT Analysis

15.2.11. Codman Neuro (Johnson & Johnson)

15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.11.2. Financial Overview

15.2.11.3. Product Portfolio

15.2.11.4. Strategic Overview

15.2.11.5. SWOT Analysis



List of Figures



Figure 01 : Global Plaque Modification Devices Market Snapshot

Figure 02: Global Plaque Modification Devices Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, 2017?2027

Figure 04: Global Plaque Modification Devices Market Value Share, by Product Type , 2018

Figure 05: Global Plaque Modification Devices Market Value Share, by Application, 2018

Figure 06: Global Plaque Modification Devices Market Value Share, by End-user, 2018

Figure 07: Global Plaque Modification Devices Market Value Share, by Region, 2018

Figure 08: Global Plaque Modification Devices Market Value Share Analysis, by Product Type , 2018 and 2027

Figure 09: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Atherectomy Devices , 2017–2027

Figure 10: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Thrombectomy Devices , 2017–2027

Figure 11: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Chronic Total Occlusion, 2017–2027

Figure 12: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Embolic Protection, 2017–2027

Figure 13: Global Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 14: Global Plaque Modification Devices Market Value Share Analysis, by Application, 2018 and 2027

Figure 15: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Coronary Disease, 2017–2027

Figure 16: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Peripheral Artery Disease, 2017–2027

Figure 17: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Neurovascular Disease, 2017–2027

Figure 18: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 19: Global Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 20 : Global Plaque Modification Devices Market Value Share Analysis, by End-user, 2018 and 2027

Figure 21: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2017–2027

Figure 22: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Specialty Clinics, 2017–2027

Figure 23: Global Plaque Modification Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgical Centers, 2017–2027

Figure 24: Global Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 25: Global Plaque Modification Devices Market Snapshot, by Country/Sub-region

Figure 26: Global Plaque Modification Devices Market Value Share Analysis, by Region 2018 and 2027

Figure 27: Global Plaque Modification Devices Market Attractiveness Analysis, by Region, 2019–2027

Figure 28: North America Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 29: North America Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 30: North America Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 31: North America Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 32: North America Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 33 : North America Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 34: North America Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 35: North America Plaque Modification Devices Market Value Share (%), by Country, 2018 and 2027

Figure 36: North America Plaque Modification Devices Market Attractiveness Analysis, by Country, 2019–2027

Figure 37: Europe Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 38: Europe Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 39: Europe Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 40: Europe Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 41: Europe Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 42: Europe Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 43: Europe Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 44: Europe Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 45: Europe Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 46: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 47: Asia Pacific Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 48: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 49: Asia Pacific Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 50: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 51: Asia Pacific Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 52: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 53: Asia Pacific Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 54: Asia Pacific Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 55: Latin America Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 56: Latin America Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 57: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 58: Latin America Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 59: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 60: Latin America Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 61: Latin America Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 62: Latin America Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 63: Latin America Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 64: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 65 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Product Type , 2018 and 2027

Figure 66: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Product Type , 2019–2027

Figure 67 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Application, 2018 and 2027

Figure 68: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Application, 2019–2027

Figure 69 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by End-user, 2018 and 2027

Figure 70: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by End-user, 2019–2027

Figure 71 : Middle East & Africa Plaque Modification Devices Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Plaque Modification Devices Market Attractiveness Analysis, by Country/Sub-region, 2019–2027


List of Tables



Table 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 04: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 05: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 07: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 08: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 09: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 11: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 12: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 13: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 14: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 15: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 17: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 18: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 19: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 22: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 23: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 24: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 27: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product Type, 2017–2027

Table 28: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 29: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 30: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027